TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Long Term Provisions | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
What is the latest Long Term Provisions ratio of TRIDENT LIFELINE ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹0.07 Cr |
| Mar2024 | ₹0.07 Cr |
| Mar2023 | ₹0.07 Cr |
| Mar2022 | ₹0.07 Cr |
How is Long Term Provisions of TRIDENT LIFELINE Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.07 Cr | 0.00 | |
| Mar2024 | ₹0.07 Cr | 0.00 | |
| Mar2023 | ₹0.07 Cr | 1.45 | |
| Mar2022 | ₹0.07 Cr | - | |
Compare Long Term Provisions of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹346.8 Cr | -4.2% | -3.5% | 2.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -4.2% |
-3.5% |
2.7% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses